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Abstract
Background: Although the Brain Attack Coalition recommended establishing centers of comprehensive care for
stroke and cerebrovascular disease patients, a scoring system for such centers was lacking. We created and validated a
comprehensive stroke center (CSC) score, adapted to Japanese circumstances.
Methods: Of the selected 1369 certified training institutions in Japan, 749 completed an acute stroke care capabilities
survey. Hospital performance was determined using a 25-item score, evaluating 5 subcategories: personnel, diagnostic
techniques, specific expertise, infrastructure, and education. Consistency and validity were examined using correlation
coefficients and factorial analysis.
Results: The CSC score (median, 14; interquartile range, 11–18) varied according to hospital volume. The five
subcategories showed moderate consistency (Cronbach’s α = 0.765). A strong correlation existed between
types of available personnel and specific expertise. Using the 2011 Japanese Diagnosis Procedure Combination
database for patients hospitalized with stroke, four constructs were identified by factorial analysis (neurovascular surgery
and intervention, vascular neurology, diagnostic neuroradiology, and neurocritical care and rehabilitation) that affected
in-hospital mortality from ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The total CSC score
was related to in-hospital mortality from ischemic stroke (odds ratio [OR], 0.973; 95% confidence interval [CI], 0.958–0.989),
intracerebral hemorrhage (OR, 0.970; 95% CI, 0.950–0.990), and subarachnoid hemorrhage (OR, 0.951; 95% CI, 0.925–0.977),
with varying contributions from the four constructs.
Conclusions: The CSC score is a valid measure for assessing CSC capabilities, based on the availability of neurovascular
surgery and intervention, vascular neurology, diagnostic neuroradiology, and critical care and rehabilitation services.
Keywords: Ischemia, Stroke, Hemorrhage, Cerebrovascular circulation, Risk factors
Background
Stroke is the fourth leading cause of mortality and the
most common cause of permanent morbidity in Japan,
causing an enormous socioeconomic burden. The public
health implications of stroke care globally, including in
Japan, are profound. Despite accelerating progress in
stroke therapy, implementation of appropriate acute
treatment remains essential for decreasing the associated
mortality and permanent morbidity. In 2000, the Brain
Attack Coalition discussed the concept of primary stroke
centers and later proposed the design of comprehensive
stroke centers (CSCs) [1, 2]. Most stroke patients can be
adequately treated at a primary stroke center (PSC), and
the Joint Commission established programs for the certi-
fication and performance measurement of PSCs [3]. The
concept and recommended key components of a CSC
enable intensive patient care and the use of specialized
techniques that are not available at most PSCs [1, 4]. To
continuously monitor the efficiency of care, reliable
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measures of hospital capabilities and performance are
needed. Although the Joint Commission and several US
states have started certification processes for PSCs and
CSCs [5–8], an established, simple scoring system does
not exist to evaluate the comprehensive acute stroke
care capabilities of CSCs. To this end, a simple tool for
assessing CSC capabilities would be useful for monitor-
ing service quality and enabling its improvement [4]. In
2010, we started the J-ASPECT study (Nationwide sur-
vey of Acute Stroke care capacity for Proper dEsignation
of Comprehensive stroke cenTer in Japan) to establish
optimal nationwide implementation of stroke centers to
improve acute stroke outcomes. We modified the above
recommendations to reflect the specific circumstances
in Japan and developed a CSC score; this tool was vali-
dated using the nationwide Diagnosis Combination Pro-




In the first step of the J-ASPECT study, we investigated
the current conditions of stroke hospitals in Japan. We
created a 49-item questionnaire examining various as-
pects of stroke care, including medical systems, emer-
gency systems, stroke rehabilitation, education, and
medical performance. Some recommended items, such
as ventriculostomy availability, were excluded from our
questionnaire for the sake of simplicity and to increase
the survey response rate since the items seemed identi-
cal to the recommendations of board-certified (BC) neu-
rosurgeons in Japan. Other items, such as availability of
transesophageal echocardiography, were excluded be-
cause of their very low expected usage, which would
make an evaluation of their impact on mortality rates
difficult. In February 2011, the questionnaire was mailed
to 1369 certified training institutions belonging to the
Japan Neurosurgical Society, the Japanese Society of
Neurology, and the Japan Stroke Society. Based on this
questionnaire, the overall organizational and staffing
levels of the hospitals, in terms of CSC capacity, were
scored following the Brain Attack Coalition recommen-
dations, after reviewing the literature describing CSCs
and conducting a thorough discussion with an expert
panel [9]. Advanced acute stroke care capabilities were
assessed based on 25 items divided into 5 subcategories
(listed in Table 1). One point was assigned for each rec-
ommended item that the hospital met, resulting in a
maximum total score of 25; subcategory scores were also
calculated.
Consistency
Cronbach’s α was calculated to evaluate the consistency
between the 5 CSC score subcategories used for
assessing CSC capabilities. To determine the influence
of each subcategory, α-values were also calculated for all
combinations of the four subcategories. Correlations be-
tween the 25 CSC score items were determined using
tetrachoric correlation coefficients to evaluate individual
items measured with different constructs.
Construct validity
Factorial analysis, based on tetrachoric correlation coef-
ficients [10], was performed using principal factor ana-
lysis to explore possible potential groupings of the 25
items into a more limited number of components. The
selection of the number of components was based on
the Eigen values. To understand the meaning of the
components, promax rotation was used.
Table 1 The availability of comprehensive stroke center score
components
Components Items Item No Number Percent
Personnel Neurologists 1 358 47.8
Neurosurgeons 2 694 92.7
Endovascular physicians 3 272 36.3




Rehabilitation therapy 6 742 99.1
Stroke rehabilitation nurses 7 102 13.6
Diagnostics
(24/7)
CTa 8 742 99.1
MRIb with diffusion 9 647 86.4
Digital cerebral angiography 10 602 80.4
CT angiography 11 627 83.7
Carotid duplex ultrasound 12 257 34.3
TCDc 13 121 16.2
Specific
expertise











Infrastructure Stroke unit 19 132 17.6
Intensive care unit 20 445 59.4




Stroke registry 23 235 31.4
Education Community education 24 369 49.3
Professional education 25 436 58.2
acomputed tomography; bmagnetic resonance imaging; ctranscranial Doppler
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Predictive validity
Using the Japanese DPC database for patients hospital-
ized with strokes during the 2011 fiscal year, we exam-
ined the differential effects of the items on mortality and
poor outcomes (modified Rankin Scale: 3–6, at dis-
charge) associated with ischemic stroke (IS), intracere-
bral hemorrhage (ICH), and subarachnoid hemorrhage
(SAH). This cross-sectional survey used the DPC dis-
charge database for the institutions participating in the
J-ASPECT study. The DPC database is a mixed-case
classification system that is linked with the lump-sum
payment system, launched in 2002 by the Ministry of
Health, Labor and Welfare of Japan [11]. In 2010, ap-
proximately 1388 acute care hospitals, representing
about 50% of the total hospital beds, had adopted the
DPC data system. Data regarding practices were ob-
tained from the DPC database; the attending physician is
responsible for each patient’s clinical data entry. The de-
tails of this database have been described elsewhere [12].
Of the 749 hospitals that responded to the institutional
survey of advanced stroke care capabilities, 256 agreed
to participate in the DPC discharge database study. Con-
secutive patients, hospitalized between April 1, 2010 and
March 31, 2011, were identified in the annual discharge
database using the International Classification of Dis-
eases (ICD)-10 diagnosis codes related to IS (I63.0-9),
nontraumatic ICH (I61.0-9, I62.0-1, I62.9), and SAH
(I60.0-9). Patients with scheduled admissions were ex-
cluded from analysis. This research was approved by the
Institutional Review Board of the National Cerebral and
Cardiovascular Center and, if required, by the participat-
ing hospitals.
We used hierarchical logistic regression models to de-
termine relationships between hospital CSC scores,
reflecting the capacities they were equipped with, and
mortality. Each model had two levels of hierarchy (hos-
pital and patient), and considered the random effects of
hospital variables as well as the fixed effects of CSC
scores, patient age and sex, and Japan Coma Scale (JCS)
scores. Interactions such as those between the JCS and
CSC scores were not included in the model. The ana-
lyses were performed using SAS, version 9.3 (SAS Insti-
tute, Cary, NC, USA), and R, version 3.2.0 (R Core
Team, R Foundation for Statistical Computing, Vienna,
Austria).
Results
Of the selected 1369 certified training institutions, 749
(55%) responded to the acute stroke care capability sur-
vey. Among the surveyed hospitals, 62% had more than
300 beds, and 51% had more than 200 acute patients
(Table 2). Clipping of intracranial aneurysms (IAs) was
performed more frequently than any other procedure
(median/hospital, 15), followed by craniotomy removal
of ICH (6), intravenous infusion of recombinant tissue
plasminogen activator (5), and coiling of IAs (3). The
availability of each item is shown in Table 1. Even within
the same component, the availability of each item varied.
Low availability values were noted for IA coiling (48.1%)
in the specific expertise component and for stroke units
(17.6%) in the infrastructure component.
The distribution of CSC score components, by hos-
pital, is shown in Table 3. The median CSC score was 14
(interquartile range, 11–18). These components showed
moderate consistency (Cronbach’s α = 0.765, for the total
score). Removal of any one component resulted in Cron-
bach’s α falling in the range of 0.668–0.776, indicating
the absence of substantial influence of individual compo-
nents. High correlations between the survey components
pertaining to personnel and specific expertise were ob-
served (Table 4). For example, there were high correla-
tions between neurosurgeon availability and carotid
endarterectomy (r = 0.821; items 2 and 14), clipping of
IAs (r = 0.936; items 2 and 15), and hematoma removal/
drainage (r = 0.949; items 2 and 16). Similarly, endovas-
cular physician availability was strongly correlated with
Table 2 Hospital characteristics





> 500 207 (27.6)
Unknown 4 (0.5)
Acute stroke patients per hospital, n (%)




> 300 228 (30.4)
Unknown 38 (5.1)
Treated patients per hospital, median (IQRa)
Tissue plasminogen activator 5 (2–10)
Intra-arterial thrombolysis/percutaneous angioplasty 0 (0–2)
Carotid endarterectomy 1 (0–4)
Carotid stenting 1 (0–7)
Extracranial-intracranial bypass surgery 1 (0–5)
Clipping of intracranial aneurysm 15 (6–27)
Coiling of intracranial aneurysm 3 (0–11)
Craniotomy hematoma removal 6 (2–12)
Stereotactic hematoma removal 0 (0–3)
Endoscopic hematoma removal 0 (0–0)
ainterquartile range
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coiling of IAs (r = 0.932; items 3 and 17) and intra-
arterial reperfusion therapy (r = 0.842; items 3 and 18).
Other relationships regarding diagnostics, infrastructure,
and education did not stand out.
Factorial analysis, based on promax rotation, revealed
four constructs (Table 5). The first pattern contained
items pertaining to neurovascular surgery and interven-
tion, such as endovascular physician availability, coiling
of IAs, intra-arterial reperfusion therapy, 24/7 interven-
tional services coverage, carotid endarterectomy,
hematoma removal/drainage, clipping of IAs, neurosur-
geon availability, rehabilitation therapy, 24/7 operating
room staffing, and stroke rehabilitation nurse availability.
The first pattern had the largest explained variance (43%
of total variance). The second pattern included imaging
modalities mainly associated with diagnostic neuroradi-
ology (e.g., computed tomography, computed tomog-
raphy angiography, digital cerebral angiography, and
diffusion-weighted magnetic resonance imaging) and in-
tensive care units. The third pattern contained items re-
lated to vascular neurology: transcranial Doppler, carotid
duplex ultrasound, professional education, community
education, stroke registry, and available stroke units. The
fourth pattern represented neurocritical care and re-
habilitation, and included the availability of neurologists,
physical medicine and rehabilitation, and critical care
medicine.
A total of 53,170 patients in the cohort were analyzed;
the in-hospital mortality was 7.8% for IS, 16.8% for ICH,
and 28.1% for SAH (Table 6). Table 7 shows the impact
of hospital capacity for each of the 25 items on mortal-
ity. Among the four constructs obtained using factorial
analysis, the availability of neurologists in neurocritical
care and rehabilitation was significantly associated with
reduced mortality of patients with IS (P < 0.05). The 24/
7 availability of interventional service coverage in neuro-
vascular surgery and intervention (P < 0.05), availability
of intensive care units in diagnostic neurology, and phys-
ical medicine and rehabilitation in neurocritical care and
rehabilitation (P < 0.05) were related to SAH mortality.
The total CSC score was related to the mortality associ-
ated with IS (OR, 0.973; 95% CI, 0.958–0.989), ICH (OR,
0.970; 95% CI, 0.950–0.990), and SAH (OR, 0.951; 95%
CI, 0.925–0.977).
The proportions of poor outcomes (modified Rankin
Scale, 3–6) were 49.2% for IS, 65.3% for ICH, and 56.4%
for SAH (Table 6). In contrast to mortality, the total
CSC score was not significantly associated with poor
outcomes in patients having any type of stroke (Table 8).
The impact of hospital capacity for each of the 25 items
on poor outcomes differed from that for mortality in
some aspects. For example, among patients with IS,
stroke unit availability were significantly associated with
a reduced proportion of poor outcomes (P < 0.05).
Among patients with ICH and SAH, no significant
association was observed between the availability of any
item and poor outcomes.
Discussion
We evaluated the consistency and validity of the CSC
score; based on the Cronbach’s α value of 0.765, the five
components were moderately consistent [13]. The valid-
ity of the score was evaluated using factorial analysis,
which revealed four major constructs. Although the four
constructs were determined by the five components:
personnel, diagnostic techniques, specific expertise, in-
frastructure, and education, this study showed a high
correlation between the survey components pertaining
to personnel and specific expertise. The unique fact that
BC neurosurgeons comprise more than 95% of BC
endovascular physicians, in Japan, may explain why
personnel, specific expertise, and infrastructure compo-
nents closely related to these different treatment aspects
were grouped into the same construct (neurovascular
surgery and intervention). Considering their influence
on the variance of the CSC scores, temporal trends and
geographical disparities focused on this construct may
provide critical information for proper accreditation and
implementation of CSCs.
With regard to the predictive validity of the CSC score,
the four constructs had different effects on mortality and
poor outcomes in patients with IS, ICH, and SAH. The
availability of neurologists involved in neurocritical care
and rehabilitation was significantly associated with re-
duced in-hospital morality in patients with IS. Recently,
the treatment paradigm for acute IS has been changing
rapidly, such that the critical role of endovascular inter-
vention following tissue plasminogen activator infusion,
for acute IS, has been established by several recent ran-
domized controlled trials (MR Clean, ESCAPE, EXTEND-
IA) [14–16]. Of note, however, the acute stroke care
survey used in this study and the DPC database were both
implemented before these evidences were published in
2015. The availability of BC neurosurgeons at more than
90% of the participating hospitals suggests the importance
of multidisciplinary acute stroke care [17].
Table 3 The distribution of comprehensive stroke center score
components and their consistency
Components Mean SD Median IQRa Cronbach’s α
Personnel 3.26 1.25 3 2–4 0.724
Diagnostic 4.00 1.28 4 4–5 0.741
Specific expertise 3.79 1.48 4 3–5 0.668
Infrastructure 2.06 1.43 2 1–3 0.674
Education 1.07 0.83 1 0–2 0.776
Total Score 14.18 4.57 14 11–18 0.765
ainterquartile range
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The association between the availability of a stroke
care unit and the increased proportion of favorable out-
comes after IS, observed in this study, is consistent with
a 2009 Cochrane review conducted by the Stroke Unit
Trialists' Collaboration that showed the benefits of
stroke unit care in terms of reducing death, dependency,
and institutional care [18].
The SAH-associated mortality was higher than that as-
sociated with IS or ICH, and the condition of the pa-
tients with SAH was also more severe and required
more urgent intervention. Accordingly, the availability of
items representing SAH treatment, such as 24/7 inter-
ventional service coverage, intensive care unit, and BC
physical medicine and rehabilitation, showed the greatest
effects on mortality. The critical role of endovascular
coil embolization for ruptured IAs was previously
established by the International Subarachnoid Aneu-
rysms Trial [19]. Using Nationwide Inpatient Survey
data, Qureshi et al. reported a significant increase in
endovascular treatment as well as a decrease in in-
hospital mortality (2000–2002, 27%; 2004–2006, 24%) in
patients with SAH after publication of the International
Subarachnoid Trial (ISAT) in 2002 [20]. However,
whether the ISAT results can be generalized to all pa-
tients with SAH is questionable because most of the
patients enrolled in the study were patients with good
clinical grades, having small, anterior circulation
aneurysms.
The second common cause of SAH-related death and
poor functional outcome is rebleeding [21], and early
treatment of the ruptured aneurysm is known to lower
the incidence of rebleeding. Intensive care unit and 24/7
Table 5 Factor analysis





Vascular neurology Neurocritical care
and rehabilitation
Proportion explained 0.43 0.25 0.19 0.14
Item No Items Standardized loadings (pattern matrix)
3 Endovascular physicians 0.91d -0.07 -0.04 0.12
17 Coiling of intracranial aneurysm 0.89 -0.11 0.04 0.15
18 Intra-arterial reperfusion therapy 0.88 0.00 0.10 -0.05
22 Interventional services coverage 24/7 0.80 -0.09 0.05 0.23
14 Carotid endarterectomy 0.76 0.24 -0.01 -0.10
16 Hematoma removal/draining 0.75 0.37 0.06 -0.16
15 Clipping of intracranial aneurysm 0.73 0.37 0.08 -0.16
2 Neurosurgeons 0.69 0.43 0.02 -0.22
6 Rehabilitation therapy 0.59 0.07 -0.63 0.18
21 Operating room staffed 24/7 0.59 0.28 0.00 0.18
7 Stroke rehabilitation nurses 0.34 -0.36 0.21 0.20
8 CTa -0.03 0.89 -0.21 0.34
11 CT angiography 0.08 0.84 0.06 -0.17
10 Digital cerebral angiography 0.36 0.70 0.08 -0.10
9 MRIb with diffusion 0.03 0.59 0.23 -0.06
20 Intensive care unit -0.06 0.50 0.17 0.22
13 TCDc 0.02 0.15 0.71 0.04
12 Carotid duplex ultrasound -0.31 0.26 0.72 0.16
25 Professional education 0.23 -0.15 0.63 -0.23
24 Community education 0.21 -0.17 0.56 0.07
23 Stroke registry 0.24 -0.08 0.52 0.10
19 Stroke unit 0.23 -0.05 0.49 0.06
1 Neurologists -0.02 -0.02 0.02 0.85
5 Physical medicine and rehabilitation 0.10 -0.09 0.00 0.72
4 Critical care medicine -0.09 0.25 0.14 0.55
acomputed tomography; bmagnetic resonance imaging; ctranscranial Doppler; dvalues > 0.300 are shown in bold font
Kada et al. BMC Neurology  (2017) 17:46 Page 6 of 11
interventional coverage availability were significant fac-
tors associated with decreasing in-hospital mortality
after SAH. These findings are explained by the import-
ance of early obliteration of ruptured aneurysms for pre-
venting rebleeding and by the early detection and
appropriate treatment of vasospasms, another important
cause of morbidity and mortality in patients with SAH.
The study provided additional evidence that the
availability of endovascular treatment and surgical
clipping may reduce in-hospital mortality in patients
with SAH [22]. Another recent study also showed
that an early mobilization program for patients with
aneurysmal SAH is feasible and safe [23]. In addition,
appropriate nutritional care from the acute stage is
reported to be essential for improving functional out-
comes and reducing post-SAH mortality [24]. Taken
together, the significant association between the avail-
ability of BC physical medicine and rehabilitation and
reduced mortality observed in our study reinforces
the importance of comprehensive care capabilities, in-
cluding early rehabilitation and nutritional care for
patients with SAH, to prevent complications. Further
investigation is required to understand the role of BC
physical medicine and rehabilitation in reducing SAH-
associated mortality.
Finally, the total CSC score correlated with reduced
mortality for all types of stroke, supporting the useful-
ness of this score as a comprehensive measure of acute
stroke care capabilities. Another study showed that
hemorrhagic stroke patients admitted to CSCs were
more likely to receive neurosurgical and endovascular
treatments and to be alive at 90 days than patients ad-
mitted to other hospitals. The authors used certification
by the New Jersey Department of Health and Senior
Services to identify CSCs. The impacts of CSCs on mor-
tality determined in that study are similar to the results
obtained using our simple scoring system [25].
In contrast to its impact on in-hospital mortality, the
total CSC score did not show a significant impact on
poor functional outcomes in patients with any type of
stroke. Similarly, no specific item had a significant im-
pact on poor outcomes in patients with hemorrhagic
stroke. In patients with IS, the significant role of the
presence of a stroke unit in reducing poor outcomes,
observed in the present study, was consistent with the
results of a previous report [26]. A validation study in-
vestigating functional outcomes using the DPC database
may be necessary to explain the disparities between the
total CSC scores (and specific items) on mortality and
poor functional outcomes.
Table 6 Demographics of the patient cohort at diagnosis, mortality, and severe disability at discharge
Total ISa ICHb SAHc
(n = 53170) (n = 32671) (n = 15699) (n = 4934)
N % N % N % N %
Male 29353 55.2 18816 57.6 9030 57.5 1584 32.1
Age (years)
18–50 3515 6.6 1328 4.1 1271 8.1 927 18.8
51–60 5824 11.0 2742 8.4 2171 13.8 934 18.9
61–70 11744 22.1 6894 21.1 3640 23.2 1242 25.2
71–80 15825 29.8 10342 31.7 4466 28.4 1048 21.2
81–106 16262 30.6 11365 34.8 4151 26.4 783 15.9
Hypertension 39918 75.1 22531 69.0 13281 84.6 4229 85.7
Diabetes mellitus 13725 25.8 9318 28.5 3278 20.9 1174 23.8
Hyperlipidemia 15015 28.2 11104 34.0 2529 16.1 1412 28.6
Smoking (n = 44842) 12761 24.0 8188 25.1 3540 22.5 1074 21.8
Japan Coma Scale
0 19635 36.9 15027 46.0 3620 23.1 1024 20.8
1-digit code 19371 36.4 12375 37.9 5934 37.8 1117 22.6
2-digit code 6937 13.0 3396 10.4 2705 17.2 852 17.3
3 digit code 7227 13.6 1873 5.7 3440 21.9 1941 39.3
Emergency admission by ambulance 31995 60.2 17336 53.1 10909 69.5 3830 77.6
Mortality 6522 12.3 2535 7.8 2630 16.8 1384 28.1
Poor outcome (modified Rankin Scale 3–6)
at discharge. (N = 51719)
28238 54.6 15566 49.2 10044 65.3 2721 56.4
aischemic stroke; bintracerebral hemorrhage; csubarachnoid hemorrhage
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Strengths and limitations of the present study
First, this study is limited by a possible selection bias
because hospitals actively working to improve stroke
care were more likely to respond to the questionnaire.
However, the coverage of the J-ASPECT Study group,
which collaborates with the Japan Neurosurgical Society
and the Japanese Congress of Neurological Surgeons,
was broad enough to provide a reliable study sample.
Second, information bias might have existed (self-report-
ing, recall, and nonresponse). Third, the CSC score
mainly evaluated structural measures and did not con-
sider their utilization, supported with real data. To as-
sess clinical practice quality, the use of process measures
is preferred [27], but process measures, such as electro-
cardiogram monitoring and pulse oximetry, were not
considered in this scoring system [4, 28]. However,
strong correlations between survey components pertain-
ing to personnel and specific expertise (e.g., availability
of neurosurgeons and carotid endarterectomy) were
observed in this study, suggesting that these items may
not be considered as purely structural, but may have
characteristics of both structural and process measures.
We are planning to develop a new registry system in the
J-ASPECT Study to include key metrics required for
certification of CSCs in the US, in addition to the DPC
database, to study and monitor the association of such
quality metrics on mortality and morbidity of acute
stroke patients, in Japan. Fourth, in-hospital mortality
was selected as an outcome measure to test the validity
of the CSC score. A recent systematic review showed
that hospital mortality does not necessarily reflect the
quality of clinical practice because mortality is affected
Table 7 The effect of items on mortality
Item ISa ICHb SAHc
No Items (n = 32671) (n = 15699) (n = 4934)
ORd 95% CIe OR 95% CI OR 95% CI
3 Endovascular physicians 0.832 0.653 1.060 0.896 0.671 1.198 1.309 0.906 1.891
17 Coiling of intracranial aneurysm 1.062 0.832 1.355 1.075 0.797 1.451 0.982 0.667 1.444
18 Intra-arterial reperfusion therapy 1.155 0.931 1.434 0.919 0.706 1.194 0.854 0.608 1.201
22 Interventional services coverage 24/7 1.071 0.831 1.379 1.145 0.844 1.555 0.674j 0.458 0.992
14 Carotid endarterectomy 0.945 0.708 1.262 0.833 0.595 1.165 0.789 0.503 1.237
15 and 16 Clipping of intracranial aneurysm
and hematoma removal/draining
0.798 0.465 1.368 0.537 0.266 1.088 0.359 0.082 1.564
2 Neurosurgeons 0.905 0.530 1.546 1.513 0.744 3.077 0.840 0.230 3.071
6 Rehabilitation therapy 1.000 1.000 1.000
21 Operating room staffed 24/7 0.986 0.826 1.176 0.956 0.769 1.187 1.217 0.921 1.610
7 Stroke rehabilitation nurses 1.021 0.831 1.253 1.019 0.803 1.293 1.074 0.803 1.436
8 CTf 0.963 0.208 4.462 0.515 0.035 7.590 1.000
11 CT angiography 1.127 0.877 1.449 0.820 0.608 1.107 0.978 0.662 1.446
10 Digital cerebral angiography 0.840 0.652 1.082 1.243 0.917 1.684 1.068 0.722 1.580
9 MRIg with diffusion 1.117 0.849 1.471 0.844 0.605 1.176 0.897 0.581 1.383
20 Intensive care unit 1.032 0.897 1.188 0.964 0.813 1.144 0.795j 0.640 0.988
13 TCDh 0.852 0.699 1.038 0.879 0.700 1.105 1.222 0.930
12 Carotid duplex ultrasound 1.039 0.889 1.215 1.021 0.849 1.228 1.119 0.891 1.406
25 Professional education 0.907 0.765 1.076 1.061 0.868 1.296 0.954 0.751 1.212
24 Community education 0.948 0.810 1.109 0.908 0.753 1.094 0.800 0.636 1.006
23 Stroke registry 0.895 0.781 1.026 0.861 0.732 1.013 0.915 0.749 1.118
19 Stroke unit 0.993 0.838 1.177 0.887 0.724 1.086 0.871 0.679 1.118
1 Neurologists 0.854j 0.742 0.982 1.043 0.881 1.234 1.110 0.901 1.367
5 Physical medicine and rehabilitation 1.025 0.844 1.245 0.976 0.777 1.225 0.746j 0.562 0.991
4 Critical care medicine 0.967 0.825 1.134 0.993 0.823 1.200 0.895 0.712 1.126
Total CSCi score 0.973j 0.958 0.989 0.970j 0.950 0.990 0.951j 0.925 0.977
aischemic stroke; bintracerebral hemorrhage; csubarachnoid hemorrhage; dOR odds ratio adjusted by hierarchical logistic model including patient age, sex, Japan
Coma Scale scores, and hospital variables; eCI confidence interval; fcomputed tomography; gmagnetic resonance imaging; htranscranial Doppler; icomprehensive
stroke center; jP < 0.05 (hierarchical logistic model)
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to a greater extent by the patients’ condition rather than
by the quality of practice [29]. Possible correlations
between specific items and mortality in patients with IS
may have been missed because of the relatively low
in-hospital mortality associated with these patients; a
larger study is necessary to resolve this issue. Fifth, the
DPC-based payment system contains limited informa-
tion regarding patient condition severity beyond post-
discharge data and the National Institute of Health
Stroke (NIHSS) Scale, Glasgow Coma Scale (GCS), ICH-
, or Hunt-Hess severity scores, upon admission. Never-
theless, the JCS is a useful tool for evaluating stroke
severity. Notably, the importance of the JCS, published
in 1974, for predicting stroke outcomes has been re-
cently reconfirmed [9, 30]. Further study is necessary to
validate the results of the present study with other
patient-level measurements, such as the NIHSS, GCS, etc.
Despite the above limitations, clear correlations were
revealed between the CSC score and in-hospital mortality
in patients with all types of strokes. In future work, the
score’s components should be weighted according to
stroke type, based on their influence on patient outcomes.
Conclusions
The CSC score is a valid measure for assessing the
capabilities of CSCs with regard to the availability of
neurovascular surgery and intervention, vascular neur-
ology, diagnostic neuroradiology, and neurocritical
care and rehabilitation. The total CSC score was
associated with mortality in patients with IS, ICH,
and SAH, with varying contributions from the four
abovementioned constructs.
Table 8 The effect of items on poor outcome (modified Rankin Scale 3–6)
Item ISa ICHb SAHc
No Items (n = 31640) (n = 15391) (n = 4821)
ORd 95% CIe OR 95% CI OR 95% CI
3 Endovascular physicians 1.180 0.890 1.563 0.896 0.671 1.198 1.267 0.856 1.875
17 Coiling of intracranial aneurysm 0.838 0.634 1.106 1.075 0.797 1.451 0.933 0.618 1.407
18 Intra-arterial reperfusion therapy 0.990 0.777 1.261 0.919 0.706 1.194 0.704 0.487 1.017
22 Interventional services coverage 24/7 0.969 0.725 1.295 1.145 0.844 1.555 0.928 0.615 1.400
14 Carotid endarterectomy 1.293 0.946 1.768 0.833 0.595 1.165 0.838 0.511 1.376
15 and 16 Clipping of intracranial aneurysm
and hematoma removal/draining
0.763 0.427 1.364 0.537 0.266 1.088 0.553 0.065 4.693
2 Neurosurgeons 1.026 0.582 1.807 1.513 0.744 3.077 4.449 0.987 20.041
6 Rehabilitation therapy 1.000 . . 1.000 . . 1.000 . .
21 Operating room staffed 24/7 0.883 0.723 1.078 0.956 0.769 1.187 0.959 0.712 1.290
7 Stroke rehabilitation nurses 0.874 0.693 1.101 1.019 0.803 1.293 0.877 0.641 1.200
8 CTf 1.328 0.296 5.956 0.515 0.035 7.590 1.000 . .
11 CT angiography 1.227 0.931 1.617 0.820 0.608 1.107 0.877 0.579 1.329
10 Digital cerebral angiography 0.912 0.685 1.213 1.243 0.917 1.684 1.274 0.842 1.928
9 MRIg with diffusion 0.940 0.706 1.252 0.844 0.605 1.176 0.793 0.490 1.284
20 Intensive care unit 0.987 0.842 1.156 0.964 0.813 1.144 1.000 0.795 1.259
13 TCDh 0.966 0.773 1.208 0.879 0.700 1.105 1.152 0.858 1.547
12 Carotid duplex ultrasound 1.183 0.988 1.415 1.021 0.849 1.228 1.206 0.945 1.538
25 Professional education 0.892 0.737 1.079 1.061 0.868 1.296 1.015 0.782 1.317
24 Community education 1.144 0.957 1.368 0.908 0.753 1.094 0.871 0.680 1.116
23 Stroke registry 0.981 0.840 1.146 0.861 0.732 1.013 0.860 0.695 1.065
19 Stroke unit 0.783j 0.645 0.952 0.887 0.724 1.086 0.878 0.676 1.141
1 Neurologists 1.137 0.969 1.335 1.043 0.881 1.234 1.096 0.877 1.370
5 Physical medicine and rehabilitation 1.163 0.934 1.449 0.976 0.777 1.225 0.979 0.725 1.322
4 Critical care medicine 1.113 0.929 1.334 0.993 0.823 1.200 1.062 0.830 1.360
Total CSCi score 0.995 0.977 1.014 1.007 0.984 1.030 0.978 0.950 1.008
aischemic stroke; bintracerebral hemorrhage; csubarachnoid hemorrhage; dOR odds ratio adjusted by hierarchical logistic model including patient age, sex, Japan
Coma Scale scores, and hospital variables; eCI: confidence interval; fcomputed tomography; gmagnetic resonance imaging; htranscranial Doppler; icomprehensive
stroke center; jP < 0.05 (hierarchical logistic model)
Kada et al. BMC Neurology  (2017) 17:46 Page 9 of 11
Abbreviations
BC: Board-certified; CI: Confidence interval; CSC: Comprehensive stroke
center; DPC: Diagnosis combination procedure; GCS: Glasgow coma scale;
IA: Intracranial aneurysm; ICH: Intracerebral hemorrhage; IS: Ischemic stroke;
ISAT: International subarachnoid trial; JCS: Japan coma scale; NIHSS: National
institute of health stroke; OR: Odds ratio; PSC: Primary stroke center;
SAH: Subarachnoid hemorrhage
Acknowledgements
We thank Drs. Manabu Hasegawa, Tomoatsu Tsuji, and Yasuhiro Nishijima
for their helpful discussions, Profs. Takamasa Kayama and Nobuo Hashimoto
for their supervision of the Japan Neurosurgical Society collaboration, and
Ms. Arisa Ishitoko for her secretarial assistance.
Funding
This work was supported by Grants-in-Aid from the Ministry of Health, Labor
and Welfare of Japan and JSPS KAKENHI Grant Number 25293314 (principal
investigator: KI). This research was partially supported by the Practical Research
Project for Life-Style related Diseases, including Cardiovascular Diseases and
Diabetes Mellitus, from the Japan Agency for Medical Research and Development.
Availability of data and materials
The datasets for this manuscript will not be shared, based on agreements
between the principal investigator and the presidents of the participating
hospitals.
Authors’ contributions
KI initiated the collaborative project. AK, KN, SK, and KI designed the study,
drafted and revised the article. AK, KN, SK monitored data collection and
analyzed the data. JN, KO, JO, YS, TA, SM, IN, KT, SM, AS, HK, FN designed the
study, and validated the survey questions from the views of physicians and
experts. All authors read and approved the final manuscript.
Competing interests
KI has received grants from Nihon Medi-Physics, AstraZeneca, and Otsuka
Pharmaceutical. JN has received an unrestricted research grant from Nihon




Ethics approval and consent to participate
Ethical approval was provided by National Cerebral and Cardiovascular
Center in Japan.
Author details
1Department of Clinical Trials and Research, Clinical Research Center, National
Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku,
Nagoya, Aichi 460-0001, Japan. 2Center for Cardiovascular Disease Information,
National Cerebral and Cardiovascular Center, Suita, Japan. 3Integrative Stroke
Imaging Center, National Cerebral and Cardiovascular Center, Suita, Japan.
4Department of Neurosurgery, Iwate Medical University, Morioka, Japan. 5Chiba
Cardiovascular Center, Ichihara, Japan. 6Department of Neurosurgery, Kyorin
University, Mitaka, Japan. 7Showa University, Tokyo, Japan. 8Department of
Neurosurgery, Osaka Medical College, Takatsuki, Japan. 9Kokura Memorial
Hospital, Fukuoka, Japan. 10Departments of Cerebrovascular Medicine, National
Cerebral and Cardiovascular Center, Suita, Japan. 11Department of Preventive
Medicine and Community Health, University of Occupational and
Environmental Health, Kita-Kyushu, Japan. 12Akita Prefectural Hospital
Organization Research Institute for Brain and Blood Vessels, Akita, Japan.
13Department of Neurosurgery, National Cerebral and Cardiovascular Center,
Suita, Japan. 14Department of Public Health, Graduate School of Medicine, The
University of Tokyo, Tokyo, Japan. 15Department of Neurosurgery, Graduate
School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Received: 25 July 2016 Accepted: 8 February 2017
References
1. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR,
et al. Recommendations for the establishment of primary stroke centers.
Brain Attack Coalition. JAMA. 2000;283:3102–9.
2. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al.
Recommendations for comprehensive stroke centers: a consensus
statement from the Brain Attack Coalition. Stroke. 2005;36:1597–616.
3. Reeves MJ, Parker C, Fonarow GC, Smith EE, Schwamm LH. Development of
stroke performance measures: definitions, methods, and current measures.
Stroke. 2010;41:1573–8.
4. Leifer D, Bravata DM, Connors 3rd JJ, Hinchey JA, Jauch EC, Johnston SC,
et al. Metrics for measuring quality of care in comprehensive stroke centers:
detailed follow-up to Brain Attack Coalition comprehensive stroke center
recommendations: a statement for healthcare professionals from the American
Heart Association/American Stroke Association. Stroke. 2011;42:849–77.
5. Markovchick VJ, Moore EE. Optimal trauma outcome: trauma system design
and the trauma team. Emerg Med Clin North Am. 2007;25:643–54.
6. Joint Commission on Accreditation of Healthcare Organizations. Updated
Primary Stroke Center Certification appendix for the disease-specific care
manual. Jt Comm Perspect. 2005;25:3–6.
7. Gropen TI, Gagliano PJ, Blake CA, Sacco RL, Kwiatkowski T, Richmond NJ, et
al. Quality improvement in acute stroke: the New York State Stroke Center
Designation Project. Neurology. 2006;67:88–93.
8. Stradling D, Yu W, Langdorf ML, Tsai F, Kostanian V, Hasso AN, et al. Stroke
care delivery before vs after JCAHO stroke center certification. Neurology.
2007;68:469–70.
9. Iihara K, Nishimura K, Kada A, Nakagawara J, Toyoda K, Ogasawara K, et al.
The impact of comprehensive stroke care capacity on the hospital volume
of stroke interventions: a nationwide study in Japan: J-ASPECT Study. J Stroke
Cerebrovasc Dis. 2014;23:1001–18.
10. Kubinger KD. On artificial results due to using factor analysis for dichotomous
variables. Psychol Sci. 2003;45:106–10.
11. Yasunaga H, Ide H, Imamura T, Ohe K. Impact of the Japanese Diagnosis
Procedure Combination-based Payment System on cardiovascular medicine-
related costs. Int Heart J. 2005;46:855–66.
12. Iihara K, Nishimura K, Kada A, Nakagawara J, Ogasawara K, Ono J, et al. Effects of
comprehensive stroke care capabilities on in-hospital mortality of patients with
ischemic and hemorrhagic stroke: J-ASPECT Study. PLoS ONE. 2014;9:e96819.
13. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al.
Quality criteria were proposed for measurement properties of health status
questionnaire. J Clin Epidemiol. 2007;60:34–42.
14. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ,
et al. A randomized trial of intraarterial treatment for acute ischemic stroke.
N Engl J Med. 2015;372:11–20.
15. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al.
Randomized assessment of rapid endovascular treatment of ischemic
stroke. N Engl J Med. 2015;372:1019–30.
16. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al.
Endovascular therapy for ischemic stroke with perfusion-imaging selection.
N Engl J Med. 2015;372:1009–18.
17. Decker C, Chhatriwalla E, Gialde E, Garavalia B, Summers D, Quinlan ME,
et al. Patient-centered decision support in acute ischemic stroke: Qualitative
study of patients’ and providers’ perspectives. Circ Cardiovasc Qual Outcomes.
2015;8 Suppl 3:S109–16.
18. Sun Y, Paulus D, Eyssen M, Maervoet J, Saka O. A systematic review and
meta-analysis of acute stroke unit care: what's beyond the statistical significance?
BMC Med Res Methodol. 2013;13:132.
19. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al.
International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping
versus endovascular coiling in 2143 patients with ruptured intracranial
aneurysms: a randomized comparison of effect on survival, dependency,
seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;
366:809–17.
20. Qureshi AI, Vazquez G, Tariq N, Suri MF, Lakshminarayan K, Lanzino G.
Impact of International Subarachnoid Aneurysm Trial results on treatment of
ruptured intracranial aneurysms in the United States. Clinical article. J Neurosurg.
2011;114:834–41.
Kada et al. BMC Neurology  (2017) 17:46 Page 10 of 11
21. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent
bleeding are the major causes of death following subarachnoid hemorrhage.
Stroke. 1994;25:1342–7.
22. Spetzler RF, McDougall CG, Albuquerque FC, Zabramski JM, Hills NK, Partovi S,
et al. The Barrow Ruptured Aneurysm Trial: 3-year results. J Neurosurg.
2013;119:146–57.
23. Olkowski BF, Devine MA, Slotnick LE, Veznedaroglu E, Liebman KM, Arcaro ML,
et al. Safety and feasibility of an early mobilization program for patients with
aneurysmal subarachnoid hemorrhage. Phys Ther. 2013;93:208–15.
24. Nagano A, Yamada Y, Miyake H, Domen K, Koyama T. Increased resting
energy expenditure after endovascular coiling for subarachnoid hemorrhage.
J Stroke Cerebrovasc Dis. 2016;25:813–8.
25. McKinney JS, Cheng JQ, Rybinnik I, Kostis JB, for the Myocardical Infarction
Data Acquisition System Study Group. Comprehensive stroke centers may
be associated with improved survival in hemorrhagic stroke. J Am Heart Assoc.
2015;4:e001448.
26. Minematsu K, Uehara T, Yasui N, Hata T, Ueda T, Okada Y, et al. Effects of
stroke unit on patient outcome: a prospective multicenter study in Japan.
Jpn J Stroke. 2007;29:59–64.
27. Lilford RJ, Brown CA, Nicholl J. Use of process measures to monitor the
quality of clinical practice. BMJ. 2007;335:648–50.
28. Uehara T, Yasui N, Okada Y, Hasegawa Y, Nagatsuka K, Minematsu K. Which
should be the essential components of stroke centers in Japan? A survey by
questionnaires sent to the directors of facilities certified by the Japan Stroke
Society. Cerebrovasc Dis. 2014;37:409–16.
29. Pitches DW, Mohammed AM, Lilford RJ. What is the empirical evidence that
hospitals with higher-risk adjusted mortality rates provide poorer quality
care? A systematic review of the literature. BMC Health Serv Res. 2007;7:91.
30. Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is
sufficient to predict stroke outcome–reintroduction of Japan Coma Scale:
A cohort study. BMJ Open. 2013;3:e002736.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kada et al. BMC Neurology  (2017) 17:46 Page 11 of 11
